Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405490
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-05-05
Brief Title:
NALIRI-XELOXAK104 for First-line Treatment of Advanced PDAC
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Drug Use |
| Nanoliposomal Irinotecan |
| Cadonilimab |
| Oxaliplatin |
| Capecitabine |
| First-Line |
| Advanced Cancer |
| Pancreatic Adenocarcinoma |